Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Operations (2017 - 2020)

enVVeno Medical has reported Cash from Operations over the past 4 years, most recently at 2613694.0 for Q4 2020.

  • For Q4 2020, Cash from Operations fell 61.02% year-over-year to 2613694.0; the TTM value through Dec 2020 reached 7677210.0, down 30.2%, while the annual FY2025 figure was 15568000.0, 7.54% up from the prior year.
  • Cash from Operations for Q4 2020 was 2613694.0 at enVVeno Medical, down from 2591648.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1152128.0 in Q1 2020 and troughed at 2613694.0 in Q4 2020.
  • A 4-year average of 1600712.79 and a median of 1469127.0 in 2018 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 22.86% in 2020 and fell as far as 91.97% in 2020.
  • Year by year, Cash from Operations stood at 1271211.0 in 2017, then dropped by 13.65% to 1444699.0 in 2018, then dropped by 12.36% to 1623221.0 in 2019, then plummeted by 61.02% to 2613694.0 in 2020.
  • Business Quant data shows Cash from Operations for NVNO at 2613694.0 in Q4 2020, 2591648.0 in Q3 2020, and 1319740.0 in Q2 2020.